Literature DB >> 24220638

Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.

Katrijn L Rensing1, Saskia C A de Jager, Erik S Stroes, Mariska Vos, Marcel Th B Twickler, Geesje M Dallinga-Thie, Carlie J M de Vries, Johan Kuiper, Ilze Bot, Jan H von der Thüsen.   

Abstract

AIM: To characterize the phenotype of Akt2/low-density-lipoprotein receptor double knockout (dKO) (Akt2/LDLr dKO) mice with respect to insulin resistance and features of atherosclerotic plaque progression. METHODS AND
RESULTS: Metabolic profile and atherosclerotic plaque progression were compared between LDLr KO mice and Akt2/LDLr dKO mice. Total cholesterol, glucose, and insulin levels were significantly higher and oral glucose tolerance test (GTT) was more impaired in Akt2/LDLr dKO mice than in LDLr KO mice. Although atherosclerotic plaques at both the carotid artery and the aortic root of Akt2/LDLr dKO mice were significantly smaller (P < 0.05) compared with LDLr KO controls, plaque composition in these mice was more complex, showing 34-50% reduced collagen content (P < 0.01), 1.4-fold larger necrotic cores (P < 0.05) and six-fold more TUNEL-positive cells (P < 0.01). In situ zymography revealed a more than two-fold higher gelatinolytic activity in Akt2/LDLr dKO mice (P < 0.05). In vitro analyses showed that deletion of Akt2 caused decreased migration, proliferation, and collagen content of vascular smooth muscle cells (VSMCs) and disturbed the balance of metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) mRNA expression in macrophages and VSMCs.
CONCLUSION: Akt2/LDLr dKO mice develop insulin resistance and complex atherosclerotic lesions. These phenotypic characteristics make Akt2/LDLr dKO mice an interesting mouse model to study the effects of insulin resistance on the development and progression of atherosclerosis.

Entities:  

Keywords:  Akt2/LDLr dKO; Atherosclerosis; Diabetes; Mouse model

Mesh:

Substances:

Year:  2013        PMID: 24220638     DOI: 10.1093/cvr/cvt252

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  16 in total

1.  Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis.

Authors:  Noemi Rotllan; Aránzazu Chamorro-Jorganes; Elisa Araldi; Amarylis C Wanschel; Binod Aryal; Juan F Aranda; Leigh Goedeke; Alessandro G Salerno; Cristina M Ramírez; William C Sessa; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  FASEB J       Date:  2014-11-12       Impact factor: 5.191

2.  Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice.

Authors:  Vladimir R Babaev; Lei Ding; Youmin Zhang; James M May; Stephen A Ramsey; Kasey C Vickers; MacRae F Linton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

3.  Identification of small proline-rich repeat protein 3 as a novel atheroprotective factor that promotes adaptive Akt signaling in vascular smooth muscle cells.

Authors:  Amanda K Segedy; Amy L Pyle; Bin Li; Youmin Zhang; Vladimir R Babaev; Parmjit Jat; Sergio Fazio; James B Atkinson; MacRae F Linton; Pampee P Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-02       Impact factor: 8.311

4.  Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.

Authors:  Noemi Rotllan; Amarylis C Wanschel; Ana Fernández-Hernando; Alessandro G Salerno; Stefan Offermanns; William C Sessa; Carlos Fernández-Hernando
Journal:  Circ Res       Date:  2015-04-13       Impact factor: 17.367

Review 5.  Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis.

Authors:  MacRae F Linton; Vladimir R Babaev; Jiansheng Huang; Edward F Linton; Huan Tao; Patricia G Yancey
Journal:  Circ J       Date:  2016-10-08       Impact factor: 2.993

6.  TMEM16A channel upregulation in arterial smooth muscle cells produces vasoconstriction during diabetes.

Authors:  M Dennis Leo; Dieniffer Peixoto-Nieves; Wen Yin; Somasundaram Raghavan; Padmapriya Muralidharan; Alejandro Mata-Daboin; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-15       Impact factor: 4.733

7.  Opposing Actions of AKT (Protein Kinase B) Isoforms in Vascular Smooth Muscle Injury and Therapeutic Response.

Authors:  Yu Jin; Yi Xie; Allison C Ostriker; Xinbo Zhang; Renjing Liu; Monica Y Lee; Kristen L Leslie; Waiho Tang; Jing Du; Seung Hee Lee; Yingdi Wang; William C Sessa; John Hwa; Jun Yu; Kathleen A Martin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-10-12       Impact factor: 8.311

8.  MK2206 attenuates atherosclerosis by inhibiting lipid accumulation, cell migration, proliferation, and inflammation.

Authors:  Ya-Qin Tang; Zhi-Wei Li; Yu-Fan Feng; Hong-Qin Yang; Cui-Liu Hou; Chi Geng; Pei-Ran Yang; Hong-Mei Zhao; Jing Wang
Journal:  Acta Pharmacol Sin       Date:  2021-07-27       Impact factor: 6.150

9.  Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice.

Authors:  Vladimir R Babaev; Katie E Hebron; Carrie B Wiese; Cynthia L Toth; Lei Ding; Youmin Zhang; James M May; Sergio Fazio; Kasey C Vickers; MacRae F Linton
Journal:  J Lipid Res       Date:  2014-09-19       Impact factor: 5.922

10.  Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions.

Authors:  Marten A Hoeksema; Marion Jj Gijbels; Jan Van den Bossche; Saskia van der Velden; Ayestha Sijm; Annette E Neele; Tom Seijkens; J Lauran Stöger; Svenja Meiler; Marieke Cs Boshuizen; Geesje M Dallinga-Thie; Johannes Hm Levels; Louis Boon; Shannon E Mullican; Nathanael J Spann; Jack P Cleutjens; Chris K Glass; Mitchell A Lazar; Carlie Jm de Vries; Erik Al Biessen; Mat Jap Daemen; Esther Lutgens; Menno Pj de Winther
Journal:  EMBO Mol Med       Date:  2014-09       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.